EquityFlow › Companies › Gedea Biotech

Gedea Biotech

Biotech · Lund, SE

Develops pHyph, an antibiotic-free vaginal infection treatment

Funding history

DateRoundAmount
May 2023Funding round
Lund biotech Gedea Biotech raised EUR1.3M to advance its antibiotic-free vaginal treatment.
$1.4M

Similar companies in Biotech

ImperagenHaga BiosciencePixelgen TechnologiesGallantChai DiscoverySNIPR BiomeCellbox LabsScope BiosciencesGenLuminaActitheraNUCLIDIUMAnocca
Explore funding flow on EquityFlow →